Amendment to Current Report — Form 8-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 8-K/A Amendment to Current Report HTML 30K
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 160K
Liquidation or Succession -- exhibit_2-1
3: EX-2.2 Plan of Acquisition, Reorganization, Arrangement, HTML 23K
Liquidation or Succession -- exhibit_2-2
4: EX-2.3 Plan of Acquisition, Reorganization, Arrangement, HTML 9K
Liquidation or Succession -- exhibit_2-3
5: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 37K
-- exhibit_3-1
6: EX-3.2 Articles of Incorporation/Organization or By-Laws HTML 147K
-- exhibit_3-2
7: EX-4.1 Instrument Defining the Rights of Security Holders HTML 18K
-- exhibit_4-1
8: EX-10.1 Material Contract -- exhibit_10-1 HTML 34K
17: EX-10.10 Material Contract -- exhibit_10-10 HTML 77K
18: EX-10.11 Material Contract -- exhibit_10-11 HTML 70K
19: EX-10.12 Material Contract -- exhibit_10-12 HTML 116K
20: EX-10.13 Material Contract -- exhibit_10-13 HTML 118K
21: EX-10.14 Material Contract -- exhibit_10-14 HTML 14K
22: EX-10.15 Material Contract -- exhibit_10-15 HTML 32K
9: EX-10.2 Material Contract -- exhibit_10-2 HTML 286K
10: EX-10.3 Material Contract -- exhibit_10-3 HTML 127K
11: EX-10.4 Material Contract -- exhibit_10-4 HTML 105K
12: EX-10.5 Material Contract -- exhibit_10-5 HTML 28K
13: EX-10.6 Material Contract -- exhibit_10-6 HTML 75K
14: EX-10.7 Material Contract -- exhibit_10-7 HTML 19K
15: EX-10.8 Material Contract -- exhibit_10-8 HTML 16K
16: EX-10.9 Material Contract -- exhibit_10-9 HTML 53K
23: EX-21.1 Subsidiaries -- exhibit_21-1 HTML 10K
24: EX-99.1 Miscellaneous Exhibit -- exhibit_99-1 HTML 241K
25: EX-99.2 Miscellaneous Exhibit -- exhibit_99-2 HTML 346K
26: EX-99.3 Miscellaneous Exhibit -- exhibit_99-3 HTML 88K
EX-10.14 — Material Contract — exhibit_10-14
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
TENTH AMENDMENT TO OPTION AGREEMENT
This amendment (“Tenth Amendment”) is being entered into by and between Advanced Inhalation Therapies Limited (“AIT”) and Pulmonox Technologies Corporation (“Pulmonox”), for the purpose of amending the Option Agreement originally entered by AIT and Pulmonox on 31st August 2015 (the “Option Agreement”).
For valid consideration, the sufficiency of which is being acknowledged by AIT and Pulmonox, it is agreed to extend the Option Period (Section 2.2 of the Option Agreement) by twelve (12) months, such that Section 2.2 of the Option Agreement shall be replaced by the following:
2.2 The Option shall be exercisable by a written notice given by the Company to Seller to that effect not later than within eighteen (18) months as of the Effective Date (the “Exercise Notice” and the “Option Period”, respectively).
IN WITNESS WHEREOF, the parties hereto have caused this Tenth Amendment to be executed by their duly authorized representatives as of the dates hereof.
|
ADVANCED INHALATION THERAPIES LIMITED
|
PULMONOX TECHNOLOGIES CORPORATION
|
|
_______________________________________
(signature)
|
_______________________________________
(signature)
|
|
Name:
______________________________________
|
Name:
______________________________________
|
|
Title:
______________________________________
|
Title:
______________________________________
|
|
Date:
______________________________________
|
Date:
______________________________________
|
